Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005929 | cilium | 4 | 12 |
GO:0042995 | cell projection | 2 | 12 |
GO:0043226 | organelle | 2 | 12 |
GO:0043227 | membrane-bounded organelle | 3 | 12 |
GO:0110165 | cellular anatomical entity | 1 | 12 |
GO:0120025 | plasma membrane bounded cell projection | 3 | 12 |
GO:0005737 | cytoplasm | 2 | 1 |
Related structures:
AlphaFold database: E9AZH8
Term | Name | Level | Count |
---|---|---|---|
GO:0006470 | protein dephosphorylation | 5 | 12 |
GO:0006793 | phosphorus metabolic process | 3 | 12 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 12 |
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0009987 | cellular process | 1 | 12 |
GO:0016311 | dephosphorylation | 5 | 12 |
GO:0019538 | protein metabolic process | 3 | 12 |
GO:0036211 | protein modification process | 4 | 12 |
GO:0043170 | macromolecule metabolic process | 3 | 12 |
GO:0043412 | macromolecule modification | 4 | 12 |
GO:0044237 | cellular metabolic process | 2 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 12 |
GO:0009966 | regulation of signal transduction | 4 | 1 |
GO:0009968 | negative regulation of signal transduction | 5 | 1 |
GO:0010646 | regulation of cell communication | 4 | 1 |
GO:0010648 | negative regulation of cell communication | 5 | 1 |
GO:0023051 | regulation of signaling | 3 | 1 |
GO:0023057 | negative regulation of signaling | 4 | 1 |
GO:0043408 | regulation of MAPK cascade | 6 | 1 |
GO:0043409 | negative regulation of MAPK cascade | 7 | 1 |
GO:0048519 | negative regulation of biological process | 3 | 1 |
GO:0048523 | negative regulation of cellular process | 4 | 1 |
GO:0048583 | regulation of response to stimulus | 3 | 1 |
GO:0048585 | negative regulation of response to stimulus | 4 | 1 |
GO:0050789 | regulation of biological process | 2 | 1 |
GO:0050794 | regulation of cellular process | 3 | 1 |
GO:0065007 | biological regulation | 1 | 1 |
GO:1902531 | regulation of intracellular signal transduction | 5 | 1 |
GO:1902532 | negative regulation of intracellular signal transduction | 6 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 12 |
GO:0004721 | phosphoprotein phosphatase activity | 3 | 12 |
GO:0008138 | protein tyrosine/serine/threonine phosphatase activity | 4 | 12 |
GO:0016787 | hydrolase activity | 2 | 12 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 12 |
GO:0016791 | phosphatase activity | 5 | 12 |
GO:0042578 | phosphoric ester hydrolase activity | 4 | 12 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 115 | 119 | PF00656 | 0.487 |
CLV_NRD_NRD_1 | 103 | 105 | PF00675 | 0.486 |
CLV_NRD_NRD_1 | 187 | 189 | PF00675 | 0.478 |
CLV_NRD_NRD_1 | 235 | 237 | PF00675 | 0.580 |
CLV_NRD_NRD_1 | 56 | 58 | PF00675 | 0.687 |
CLV_PCSK_KEX2_1 | 187 | 189 | PF00082 | 0.465 |
CLV_PCSK_KEX2_1 | 235 | 237 | PF00082 | 0.574 |
CLV_PCSK_KEX2_1 | 240 | 242 | PF00082 | 0.324 |
CLV_PCSK_PC1ET2_1 | 240 | 242 | PF00082 | 0.481 |
CLV_PCSK_PC7_1 | 236 | 242 | PF00082 | 0.544 |
CLV_PCSK_SKI1_1 | 230 | 234 | PF00082 | 0.356 |
CLV_PCSK_SKI1_1 | 241 | 245 | PF00082 | 0.384 |
CLV_PCSK_SKI1_1 | 355 | 359 | PF00082 | 0.337 |
CLV_PCSK_SKI1_1 | 367 | 371 | PF00082 | 0.309 |
CLV_PCSK_SKI1_1 | 380 | 384 | PF00082 | 0.328 |
DOC_CDC14_PxL_1 | 146 | 154 | PF14671 | 0.402 |
DOC_CYCLIN_yClb5_NLxxxL_5 | 133 | 142 | PF00134 | 0.517 |
DOC_CYCLIN_yCln2_LP_2 | 222 | 228 | PF00134 | 0.454 |
DOC_MAPK_gen_1 | 240 | 246 | PF00069 | 0.428 |
DOC_MAPK_gen_1 | 249 | 258 | PF00069 | 0.447 |
DOC_MAPK_gen_1 | 351 | 359 | PF00069 | 0.372 |
DOC_MAPK_gen_1 | 54 | 64 | PF00069 | 0.627 |
DOC_MAPK_RevD_3 | 220 | 236 | PF00069 | 0.253 |
DOC_PP2B_LxvP_1 | 324 | 327 | PF13499 | 0.340 |
DOC_PP4_FxxP_1 | 147 | 150 | PF00568 | 0.406 |
DOC_USP7_MATH_1 | 332 | 336 | PF00917 | 0.398 |
DOC_USP7_MATH_1 | 6 | 10 | PF00917 | 0.638 |
DOC_USP7_MATH_1 | 93 | 97 | PF00917 | 0.464 |
DOC_USP7_UBL2_3 | 54 | 58 | PF12436 | 0.729 |
DOC_WW_Pin1_4 | 31 | 36 | PF00397 | 0.634 |
LIG_14-3-3_CanoR_1 | 104 | 109 | PF00244 | 0.280 |
LIG_14-3-3_CanoR_1 | 235 | 244 | PF00244 | 0.461 |
LIG_14-3-3_CanoR_1 | 290 | 296 | PF00244 | 0.375 |
LIG_14-3-3_CanoR_1 | 57 | 64 | PF00244 | 0.568 |
LIG_14-3-3_CanoR_1 | 79 | 83 | PF00244 | 0.519 |
LIG_14-3-3_CanoR_1 | 90 | 98 | PF00244 | 0.418 |
LIG_Actin_WH2_2 | 277 | 292 | PF00022 | 0.328 |
LIG_Actin_WH2_2 | 366 | 382 | PF00022 | 0.475 |
LIG_Actin_WH2_2 | 91 | 106 | PF00022 | 0.472 |
LIG_AP2alpha_1 | 340 | 344 | PF02296 | 0.475 |
LIG_AP2alpha_2 | 180 | 182 | PF02296 | 0.494 |
LIG_APCC_ABBA_1 | 295 | 300 | PF00400 | 0.413 |
LIG_APCC_ABBA_1 | 337 | 342 | PF00400 | 0.437 |
LIG_APCC_ABBA_1 | 408 | 413 | PF00400 | 0.262 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.679 |
LIG_BRCT_BRCA1_1 | 122 | 126 | PF00533 | 0.293 |
LIG_BRCT_BRCA1_1 | 163 | 167 | PF00533 | 0.519 |
LIG_BRCT_BRCA1_1 | 27 | 31 | PF00533 | 0.751 |
LIG_FHA_1 | 134 | 140 | PF00498 | 0.486 |
LIG_FHA_1 | 292 | 298 | PF00498 | 0.333 |
LIG_FHA_1 | 368 | 374 | PF00498 | 0.385 |
LIG_FHA_1 | 47 | 53 | PF00498 | 0.710 |
LIG_FHA_2 | 381 | 387 | PF00498 | 0.364 |
LIG_FHA_2 | 65 | 71 | PF00498 | 0.609 |
LIG_LIR_Apic_2 | 145 | 150 | PF02991 | 0.473 |
LIG_LIR_Gen_1 | 164 | 173 | PF02991 | 0.540 |
LIG_LIR_Gen_1 | 211 | 222 | PF02991 | 0.516 |
LIG_LIR_Gen_1 | 264 | 275 | PF02991 | 0.428 |
LIG_LIR_Gen_1 | 282 | 289 | PF02991 | 0.413 |
LIG_LIR_Gen_1 | 296 | 306 | PF02991 | 0.413 |
LIG_LIR_Gen_1 | 8 | 15 | PF02991 | 0.626 |
LIG_LIR_Nem_3 | 123 | 129 | PF02991 | 0.526 |
LIG_LIR_Nem_3 | 164 | 170 | PF02991 | 0.551 |
LIG_LIR_Nem_3 | 264 | 270 | PF02991 | 0.435 |
LIG_LIR_Nem_3 | 282 | 286 | PF02991 | 0.400 |
LIG_LIR_Nem_3 | 296 | 301 | PF02991 | 0.226 |
LIG_LIR_Nem_3 | 341 | 347 | PF02991 | 0.345 |
LIG_LIR_Nem_3 | 8 | 13 | PF02991 | 0.597 |
LIG_LYPXL_L_2 | 275 | 284 | PF13949 | 0.421 |
LIG_Pex14_2 | 340 | 344 | PF04695 | 0.348 |
LIG_SH2_CRK | 228 | 232 | PF00017 | 0.560 |
LIG_SH2_SRC | 148 | 151 | PF00017 | 0.442 |
LIG_SH2_STAP1 | 228 | 232 | PF00017 | 0.366 |
LIG_SH2_STAP1 | 411 | 415 | PF00017 | 0.363 |
LIG_SH2_STAT5 | 148 | 151 | PF00017 | 0.512 |
LIG_SH2_STAT5 | 283 | 286 | PF00017 | 0.371 |
LIG_SH2_STAT5 | 305 | 308 | PF00017 | 0.344 |
LIG_SH2_STAT5 | 375 | 378 | PF00017 | 0.328 |
LIG_SH2_STAT5 | 39 | 42 | PF00017 | 0.587 |
LIG_SH3_3 | 111 | 117 | PF00018 | 0.536 |
LIG_SH3_3 | 178 | 184 | PF00018 | 0.484 |
LIG_SH3_3 | 313 | 319 | PF00018 | 0.413 |
LIG_SH3_3 | 32 | 38 | PF00018 | 0.573 |
LIG_Sin3_3 | 387 | 394 | PF02671 | 0.449 |
LIG_SUMO_SIM_anti_2 | 312 | 318 | PF11976 | 0.184 |
LIG_SUMO_SIM_anti_2 | 385 | 392 | PF11976 | 0.449 |
LIG_SUMO_SIM_par_1 | 112 | 118 | PF11976 | 0.467 |
LIG_SUMO_SIM_par_1 | 199 | 205 | PF11976 | 0.505 |
LIG_TRAF2_1 | 209 | 212 | PF00917 | 0.463 |
LIG_TRAF2_1 | 67 | 70 | PF00917 | 0.499 |
LIG_TYR_ITIM | 226 | 231 | PF00017 | 0.540 |
LIG_TYR_ITIM | 281 | 286 | PF00017 | 0.521 |
LIG_UBA3_1 | 376 | 380 | PF00899 | 0.449 |
LIG_WRC_WIRS_1 | 7 | 12 | PF05994 | 0.623 |
MOD_CDK_SPK_2 | 31 | 36 | PF00069 | 0.457 |
MOD_CK1_1 | 161 | 167 | PF00069 | 0.499 |
MOD_CK1_1 | 23 | 29 | PF00069 | 0.673 |
MOD_CK1_1 | 288 | 294 | PF00069 | 0.328 |
MOD_CK1_1 | 60 | 66 | PF00069 | 0.610 |
MOD_CK1_1 | 78 | 84 | PF00069 | 0.386 |
MOD_CK2_1 | 104 | 110 | PF00069 | 0.534 |
MOD_CK2_1 | 199 | 205 | PF00069 | 0.505 |
MOD_CK2_1 | 206 | 212 | PF00069 | 0.392 |
MOD_CK2_1 | 62 | 68 | PF00069 | 0.570 |
MOD_GlcNHglycan | 122 | 125 | PF01048 | 0.549 |
MOD_GlcNHglycan | 19 | 25 | PF01048 | 0.582 |
MOD_GlcNHglycan | 46 | 49 | PF01048 | 0.614 |
MOD_GlcNHglycan | 59 | 62 | PF01048 | 0.689 |
MOD_GlcNHglycan | 86 | 89 | PF01048 | 0.423 |
MOD_GlcNHglycan | 91 | 94 | PF01048 | 0.449 |
MOD_GSK3_1 | 133 | 140 | PF00069 | 0.402 |
MOD_GSK3_1 | 25 | 32 | PF00069 | 0.713 |
MOD_GSK3_1 | 363 | 370 | PF00069 | 0.328 |
MOD_GSK3_1 | 414 | 421 | PF00069 | 0.622 |
MOD_GSK3_1 | 42 | 49 | PF00069 | 0.458 |
MOD_GSK3_1 | 60 | 67 | PF00069 | 0.529 |
MOD_GSK3_1 | 89 | 96 | PF00069 | 0.460 |
MOD_LATS_1 | 378 | 384 | PF00433 | 0.410 |
MOD_LATS_1 | 416 | 422 | PF00433 | 0.344 |
MOD_N-GLC_1 | 158 | 163 | PF02516 | 0.442 |
MOD_N-GLC_1 | 29 | 34 | PF02516 | 0.649 |
MOD_N-GLC_1 | 84 | 89 | PF02516 | 0.388 |
MOD_NEK2_1 | 120 | 125 | PF00069 | 0.547 |
MOD_NEK2_1 | 138 | 143 | PF00069 | 0.322 |
MOD_NEK2_1 | 285 | 290 | PF00069 | 0.435 |
MOD_NEK2_1 | 365 | 370 | PF00069 | 0.337 |
MOD_NEK2_1 | 414 | 419 | PF00069 | 0.510 |
MOD_NEK2_1 | 89 | 94 | PF00069 | 0.495 |
MOD_PKA_1 | 104 | 110 | PF00069 | 0.516 |
MOD_PKA_1 | 235 | 241 | PF00069 | 0.481 |
MOD_PKA_1 | 57 | 63 | PF00069 | 0.639 |
MOD_PKA_2 | 235 | 241 | PF00069 | 0.508 |
MOD_PKA_2 | 78 | 84 | PF00069 | 0.506 |
MOD_PKA_2 | 89 | 95 | PF00069 | 0.409 |
MOD_Plk_1 | 158 | 164 | PF00069 | 0.437 |
MOD_Plk_1 | 332 | 338 | PF00069 | 0.475 |
MOD_Plk_1 | 75 | 81 | PF00069 | 0.452 |
MOD_Plk_1 | 84 | 90 | PF00069 | 0.362 |
MOD_Plk_2-3 | 15 | 21 | PF00069 | 0.690 |
MOD_Plk_4 | 142 | 148 | PF00069 | 0.397 |
MOD_Plk_4 | 199 | 205 | PF00069 | 0.505 |
MOD_Plk_4 | 293 | 299 | PF00069 | 0.388 |
MOD_Plk_4 | 332 | 338 | PF00069 | 0.398 |
MOD_ProDKin_1 | 31 | 37 | PF00069 | 0.635 |
MOD_SUMO_rev_2 | 9 | 18 | PF00179 | 0.681 |
TRG_DiLeu_BaLyEn_6 | 227 | 232 | PF01217 | 0.256 |
TRG_ENDOCYTIC_2 | 228 | 231 | PF00928 | 0.513 |
TRG_ENDOCYTIC_2 | 283 | 286 | PF00928 | 0.470 |
TRG_ENDOCYTIC_2 | 298 | 301 | PF00928 | 0.186 |
TRG_ENDOCYTIC_2 | 411 | 414 | PF00928 | 0.449 |
TRG_ER_diArg_1 | 186 | 188 | PF00400 | 0.506 |
TRG_ER_diArg_1 | 234 | 236 | PF00400 | 0.534 |
TRG_ER_diArg_1 | 249 | 252 | PF00400 | 0.452 |
TRG_Pf-PMV_PEXEL_1 | 345 | 349 | PF00026 | 0.458 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PE85 | Leptomonas seymouri | 66% | 100% |
A0A0S4IVI6 | Bodo saltans | 32% | 100% |
A0A1X0NVC7 | Trypanosomatidae | 47% | 100% |
A0A3Q8IEF5 | Leishmania donovani | 93% | 100% |
A0A3R7KS85 | Trypanosoma rangeli | 47% | 100% |
A4HG58 | Leishmania braziliensis | 81% | 100% |
A4I390 | Leishmania infantum | 93% | 100% |
D0A7R6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 45% | 100% |
Q4Q8Q3 | Leishmania major | 92% | 100% |
V5B7J4 | Trypanosoma cruzi | 48% | 100% |